Table 2.
Clinicopathological Characteristics of patients.
| PCa Patients with de novo metastatic disease | |
| Characteristic (Initial PCa Staging) | No. (%) of PCa (N = 56) |
| Median age at diagnosis (years) (range) | 70.14 (49–88%) |
| PSA (median 75.9 ng/mL; range 2.38–6806) | |
| ≤100 | 30 (53.6%) |
| >100 | 23 (41.1%) |
| Missing | 3 (5.4%) |
| Gleason Score | |
| ≤7 | 10 (17.9%) |
| 8 | 14 (25%) |
| ≥9 | 27 (48.2%) |
| Missing | 5 (8.9%) |
| ISUP Grade group | |
| 1 | 2 (3.6%) |
| 2 | 2 (3.6%) |
| 3 | 6 (10.7%) |
| 4 | 14 (25%) |
| 5 | 27 (48.2%) |
| Missing | 5 (8.9%) |
| Nodal Status a | |
| Positive | 29 (51.9%) |
| Negative | 24 (42.9%) |
| Missing | 3 (5.4%) |
| Bone Metastasis b | |
| Positive | 46 (82.1%) |
| Negative | 7 (12.5%) |
| Missing | 3 (5.4%) |
| High-Volume PCa (visceral metastases and/or 4 or more bone metastases) | |
| Positive | 28 (50%) |
| Negative | 25 (44.6%) |
| Missing | 3 (5%) |
| ECOG PS | |
| 0 | 31 (55.4%) |
| ≥1 | 25 (44.6%) |
| PAIN | |
| Present | 33 (58.9%) |
| Absent | 23 (41.1%) |
| Ethnicity | |
| Caucasian | 54 (96.4%) |
| African American | 1 (1.8%) |
| Asian | 1 (1.8%) |
a As reported by Computed Tomography (CT) scan (abdominal). b As defined by Whole Body Bone Scan (WBS).